![Inside Honeywell’s plan for a new F-35 cooling system [Video]](https://breakingdefense.com/wp-content/uploads/sites/3/2024/07/8509355-1-scaled-e1721820217290.jpg?#)
Insmed's 'unprecedented' phase 2 PAH win sends stock soaring as the race to phase 3 kicks off
Insmed hopes to bring treprostinil palmitil inhalation powder, a prodrug of United Therapeutics' blockbuster PAH mainstay Tyvaso, to phase 3 development by the end of this year.
Insmed hopes to bring treprostinil palmitil inhalation powder, a prodrug of United Therapeutics' blockbuster PAH mainstay Tyvaso, to phase 3 development by the end of this year.
